Checkpoint Blockade Finally Breaks Through in Ovarian Cancer

By News Health
2 months Ago

(MedPage Today) — BERLIN — After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall survival (OS) benefit in ovarian cancer, phase III study results showed.
KEYNOTE-B96 enrolled patients…

Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118021

Author :

Publish date : 2025-10-19 18:10:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Epidural kit shortage could last until March, regulator says

'Parents Are Going to Be Very Scared for No Reason': What We Heard This Week

Living and Light - BBC Sounds

Doctors v. Advanced Practice Providers: A False Fault Line in Medicine

State's Autism, Addiction Programs Hit by Massive Fraud Scheme, Official Says

Amy Sedaris Shares How She Stays Mentally Sharp and Young at Heart